ClinicalTrials.gg
RecruitingNCT07029802Updated Jun 18, 2026

Development of a Novel Evaluation Scale of Mental Body Representation (MBR) for Adults With Spinal Cord Injury

An observational study in Spinal Cord Injuries, sponsored by University of Minnesota. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-18.

Sponsored by University of Minnesota · Observational

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
80
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Spinal Cord Injuries by University of Minnesota — 7 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · University of Minnesota.

Started
2024
with 1 other
Observational
3 of 15
2 open now
Registered
14th of 15
by date

Among the 15 studies in Spinal Cord Injuries by University of Minnesota, this one is one of 2 that started in 2024, is one of 3 observational ones, and was the 14th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

7 of the 15 studies in Spinal Cord Injuries by University of Minnesota are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Spinal Cord Injuries by University of Minnesota, or all of them as a file.
02

Study summary

The purpose of this study is twofold: (1) Develop a new evaluation scale for mental body representations (MBR, i.e., body awareness and visuospatial body maps) for adults with spinal cord injury (SCI) with and without neuropathic pain. (2) Assess the psychometric properties of usability, reliability, and validity of the new evaluation scale This is a cross-sectional observational study design. For Aim 1, this study will involve initial item generation for a novel MBR evaluation scale for SCI through email communication, and individual interviews proctored remotely through Zoom, or, if preferred by the participant, in-person. For Aim 2, the study will include a Zoom call for consenting and questionnaires, as well as an in-person visit where participants will be tested with the new SCI-BodyMap evaluation scale, and a questionnaire asking about the usability and satisfaction of the new evaluation scale.

03

Conditions studied

  • Spinal Cord Injuries
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

For all adults with SCI in this study: 18+ years old, participants with an incomplete or complete SCI of ≥ 1 year, medically stable, able to read and understand English, having access to the internet/iPad/computer/phone and willing to come in for an in-person testing at the University of Minnesota.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Control group

  • Uninjured adults (from the contact list with the Brain Body Mind lab or through fliers or StudyFinder)
  • 18+ years old adults

SCI group

  • 18+ years old, participants with an incomplete or complete SCI of ≥ 1 year
  • medically stable
  • able to read and understand English
  • having access to the internet/iPad/computer/phone and willing to come in for an in-person testing at the University of Minnesota.

Exclusion criteria

Exclusion Criteria:

SCI group

  • Uncontrolled seizure disorder;
  • cognitive impairment and/or communicative disability (e.g., due to brain injury) preventing them from following directions or from learning;
  • ventilator dependency;
  • major medical complications;
  • pressure ulcers hindering prolonged sitting or lying down.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Participants with SCI

    Other: No intervention

  • Uninjured participants

    Other: No intervention

Interventions

  • OtherNo intervention

    This is an observational study

06

What researchers measure

Primary outcomes

  1. Reliability of the scale

    Inter-rater reliability of the new SCI-BodyMap scale (scores from two physical or occupational therapists testing the same participants) will be evaluated with Kappa and ICC.

    Time frame: 1 week

  2. Validity of the scale

    Convergent validity of the newly developed SCI-BodyMap scale for SCI will be tested with Spearman rho correlations between the new MBR scale and the Revised Body awareness scale, Multidimensional Assessment lnteroceptive Awareness-2 (MAIA- 2), lowest, average and highest neuropathic pain levels with the Numeric Pain Rating Scale (NPRS), and the NINOS-COE SCI Functional lndex/Assistive Technology Scale (SCI/Fl-AT).

    Time frame: 1 week

  3. establish the minimal detectable difference (MDD)

    The Minimal Detectable Difference (MOD) will be calculated using the standard error of measurement.

    Time frame: 1 week

Secondary outcomes

  1. QQ-10 scale, to assess the usability of the new MBR scale.

    This will be complemented by open-ended questions about the scale from the point of view of the participant with SCI and the therapists who evaluated the participant with the new scale.

    Time frame: 1 week

  2. SCI-related symptoms (Penn Spasm Frequency Scale

    We will assess the frequency and severity of spasms (Penn Spasm Frequency Scale),

    Time frame: 1 week

  3. SCI-related symptoms (BARQ-R)

    We will assess body awareness related to the participant's perception of tension in the body (BARQ-R)

    Time frame: 1 week

  4. SCI-related symptoms (MAIA-2)

    We will assess interoceptive awareness (MAIA-2).

    Time frame: 1 week

  5. Physical functioning.

    We will measure function related to basic mobility, self-care, fine motor function, and ambulation (NINOS-COE SCI/Fl-AT)

    Time frame: 1 week

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Jun 2027, 30 months after the start.

Of 124 non-industry observational studies under Spinal Cord Injuries, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 74. This study's planned 30 months is below that.

Counting every sponsor, half of 135 studies reached it within 39 months; a quarter within 16 and three quarters within 82.

How these figures are worked out, and which studies are left out of them.

Registered
May 30, 2025
First posted
Jun 19, 2025
StartActual
Nov 18, 2024
Primary completionEst.
Jun 15, 2027
CompletionEst.
Jun 15, 2027
Last update
Jun 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07029802
Responsible party
Sponsor
First posted
Jun 19, 2025
Start date
Nov 18, 2024
Primary completion
Jun 15, 2027 (estimated)
Completion
Jun 15, 2027 (estimated)
Last update
Jun 18, 2026

Study contacts

Sydney Carpentier
Contact
carpe749@umn.edu
562-508-9693
Ann Van de Winckel
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion